Akorn Inc (AKRXQ) Return on Assets ROA from the second quarter of 2020 to second quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Jun 30 2020 to Jun 30 2019 - CSIMarket
CSIMarket
 


Akorn Inc  (AKRXQ)


Akorn Inc's ROA from the second quarter of 2020 to the second quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Akorn Inc's ROA in the second quarter of 2020?
Akorn Inc recorded a cumulative net loss of $-71 million during 12 months ending in the second quarter of 2020, resulting in a negative return on assets (ROA) of -5.98%.

However, within the Healthcare sector 247 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2020 quarter, so far to 3098, from total ROA ranking in the first quarter of 2020 at 3360.

What is ROA?



Return On Assets (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Total Assets Change -29.16 % -28.17 % -13.82 % -18.47 % -20.84 %
Y / Y Net Income Change - - -7.18 % - -
Net Income (TTM) in million -71 -114 61 77 -41
Return On Assets (TTM) -5.98 % -8.85 % 4.41 % 5.36 % -2.69 %
AKRXQ's Total Ranking # 3098 # 3360 # 1432 # 1204 # 3222
Total Assets (TTM) in million 1,002 1,032 1,289 1,398 1,414
Seq. Total Assets Change -2.96 % -19.89 % -7.85 % -1.12 % -1.6 %
Seq. Net Income Change - - 334.48 % - -



Return On Assets Company Ranking
Within: No.
Industry # 83
Sector # 248
Overall # 2998

Return On Assets Statistics
High Average Low
12.98 %
2.9 %
-13.86 %
(Dec 31 2013)   (Sep 30 2018)





Financial Statements
Akorn Inc's Assets $ 1,002 million AKRXQ's Balance sheet
Akorn Inc's Income $ -69 million Quarterly AKRXQ's Income Statement
AKRXQ's Income by Division See AKRXQ's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
(Dec 31 2016)
FY 2016
(Dec 31 2015)
FY 2015
Y / Y Total Assets Change -13.82 % -21.69 % -3.25 % -6.58 % 10.79 %
Total Assets in million 1,289 1,495 1,910 1,974 2,113
Y / Y Net Income Change 68.19 % - - - -
Net Income in million 61 36 -25 184 0
Annual Return On Assets 4.73 % 2.43 % -1.29 % 9.33 % 0 %




Comment on AKRXQ's ROA in the fiscal year ending 2019
In the fiscal year 2019 ROA improved to 4.73 % compared to prior year, due to annual net income growth of 68.19 % to $61.01 million, and due to decline of value in Akorn Inc's assets by -13.82 % to $1,288.64 million, compared to $1,288.64 a year before.


More Return On Assets Ratios
AKRXQ's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AKRXQ's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AKRXQ's Competitors
Subscribers only: Roa for Akorn Inc's Suppliers
Subscribers only: Return On Assets for AKRXQ's Customers

You may also want to know
AKRXQ's Roi AKRXQ's Inventory Turnover Ratio AKRXQ's Growth Rates AKRXQ's Dividend Comparisons
AKRXQ's Profitability Ratios AKRXQ's Asset Turnover Ratio AKRXQ's Dividend Growth
AKRXQ's Roe AKRXQ's Valuation Ratios AKRXQ's Financial Strength Ratios AKRXQ's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2020, within Healthcare Sector ROA


Date modified: 2026-08-29T17:34:59+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.